Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Introduction. Primary and secondary infections of the brain.

Lewis A, Raheja A, McCutcheon IE.

Neurosurg Focus. 2019 Aug 1;47(2):E1. doi: 10.3171/2019.5.FOCUS19390. No abstract available.

PMID:
31370012
2.

Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

Ferguson SD, Bindal S, Bassett RL Jr, Haydu LE, McCutcheon IE, Heimberger AB, Li J, O'Brien BJ, Guha-Thakurta N, Tetzlaff MT, Tawbi H, Davies MA, Glitza IC.

J Neurooncol. 2019 May;142(3):499-509. doi: 10.1007/s11060-019-03121-2. Epub 2019 Mar 7.

PMID:
30847840
3.

Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.

Al-Holou WN, Hodges TR, Everson RG, Freeman J, Zhou S, Suki D, Rao G, Ferguson SD, Heimberger AB, McCutcheon IE, Prabhu SS, Lang FF, Weinberg JS, Wildrick DM, Sawaya R.

Neurosurgery. 2019 Feb 25. pii: nyz008. doi: 10.1093/neuros/nyz008. [Epub ahead of print]

PMID:
30799490
4.

Association between intravenous acetaminophen and reduction in intraoperative opioid consumption during transsphenoidal surgery for pituitary tumors.

Banerjee U, Hagan K, Bhavsar S, Grasu R, Dang A, McCutcheon IE, Suarez M, Gottumukkala V, Cata JP.

J Anaesthesiol Clin Pharmacol. 2018 Oct-Dec;34(4):465-471. doi: 10.4103/joacp.JOACP_276_17.

5.

Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.

Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SF.

Lancet Oncol. 2018 Oct;19(10):1351-1359. doi: 10.1016/S1470-2045(18)30487-X. Epub 2018 Sep 17.

PMID:
30236511
6.

Pilot study of dovitinib in patients with von Hippel-Lindau disease.

Pilié P, Hasanov E, Matin SF, Woodson AHH, Marcott VD, Bird S, Slack RS, Fuller GN, McCutcheon IE, Jonasch E.

Oncotarget. 2018 May 4;9(34):23390-23395. doi: 10.18632/oncotarget.25171. eCollection 2018 May 4.

7.

Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.

Mojtahedzadeh M, Shaesteh N, Haykani M, Tran JLA, Mangubat M, Shahinian HK, Nachnani R, Zopey M, Saidian J, Thomas A, Lee ML, McCutcheon IE, Friedman TC.

Horm Metab Res. 2018 Jun;50(6):453-461. doi: 10.1055/a-0603-3868. Epub 2018 May 2.

8.

Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.

Glitza IC, Rohlfs M, Guha-Thakurta N, Bassett RL Jr, Bernatchez C, Diab A, Woodman SE, Yee C, Amaria RN, Patel SP, Tawbi H, Wong M, Hwu WJ, Hwu P, Heimberger A, McCutcheon IE, Papadopoulos N, Davies MA.

ESMO Open. 2018 Jan 24;3(1):e000283. doi: 10.1136/esmoopen-2017-000283. eCollection 2018.

9.

Surgical Management of Gliomas in Eloquent Cortex.

Ferguson SD, McCutcheon IE.

Prog Neurol Surg. 2018;30:159-172. doi: 10.1159/000464391. Epub 2017 Dec 14. Review.

PMID:
29241173
10.

Rationale for Aggressive Resection and General Surgical Principles for Intracranial Gliomas.

McCutcheon IE, Chernov MF.

Prog Neurol Surg. 2018;30:63-105. doi: 10.1159/000464369. Epub 2017 Dec 14. Review.

PMID:
29241170
11.

The surgical treatment of metastatic spine tumors within the intramedullary compartment.

Strickland BA, McCutcheon IE, Chakrabarti I, Rhines LD, Weinberg JS.

J Neurosurg Spine. 2018 Jan;28(1):79-87. doi: 10.3171/2017.5.SPINE161161. Epub 2017 Nov 10.

PMID:
29125427
12.

Interbody distraction and vertebral body reconstruction with polymethylmethacrylate for the treatment of pathological fractures.

Zuckerman SL, Rao G, Rhines LD, McCutcheon IE, Everson RG, Tatsui CE.

J Neurosurg Spine. 2017 Dec;27(6):700-708. doi: 10.3171/2017.4.SPINE161182. Epub 2017 Oct 6.

PMID:
28984511
13.

Neurosurgical management of brain metastases.

Ferguson SD, Wagner KM, Prabhu SS, McAleer MF, McCutcheon IE, Sawaya R.

Clin Exp Metastasis. 2017 Oct;34(6-7):377-389. doi: 10.1007/s10585-017-9860-z. Epub 2017 Sep 30. Review.

PMID:
28965270
14.

Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers.

Young ED, Ingram D, Metcalf-Doetsch W, Khan D, Al Sannaa G, Le Loarer F, Lazar AJF, Slopis J, Torres KE, Lev D, Pollock RE, McCutcheon IE.

J Neurosurg. 2018 Sep;129(3):805-814. doi: 10.3171/2017.2.JNS153004. Epub 2017 Sep 8. Erratum in: J Neurosurg. 2018 Sep 1;129(3):838.

PMID:
28885122
15.

HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.

Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, Tong X, Tannir NM, Matin SF, Rathmell WK, Fuller GN, McCutcheon IE, Walker CL, Wang J, Jonasch E.

Cancer Res. 2017 Oct 1;77(19):5313-5326. doi: 10.1158/0008-5472.CAN-17-0986. Epub 2017 Aug 14.

16.

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.

Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G.

Lancet Oncol. 2017 Aug;18(8):1040-1048. doi: 10.1016/S1470-2045(17)30414-X. Epub 2017 Jul 4. Erratum in: Lancet Oncol. 2017 Aug;18(8):e433. Lancet Oncol. 2017 Sep;18(9):e510.

17.

The surgical treatment of tumors of the fourth ventricle: a single-institution experience.

Ferguson SD, Levine NB, Suki D, Tsung AJ, Lang FF, Sawaya R, Weinberg JS, McCutcheon IE.

J Neurosurg. 2018 Feb;128(2):339-351. doi: 10.3171/2016.11.JNS161167. Epub 2017 Apr 14.

PMID:
28409732
18.

Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients: A tertiary care cancer hospital experience.

Mayer RR, Frankfort BJ, Strickland BA, Debnam JM, McCutcheon IE, Groves MD, Weinberg JS.

J Clin Neurosci. 2017 May;39:151-154. doi: 10.1016/j.jocn.2017.01.024. Epub 2017 Feb 16.

PMID:
28215459
19.

Metastatic Adenoid Cystic Carcinoma Mimicking Butterfly Glioblastoma: A Rare Presentation in the Splenium of the Corpus Callosum.

Garber ST, Khoury L, Bell D, Schomer DF, Janku F, McCutcheon IE.

World Neurosurg. 2016 Nov;95:621.e13-621.e19. doi: 10.1016/j.wneu.2016.07.111. Epub 2016 Aug 10.

PMID:
27521725
20.

Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.

Kamiya-Matsuoka C, Cachia D, Waguespack SG, Crane CH, Mahajan A, Brown PD, Nam JY, McCutcheon IE, Penas-Prado M.

Pituitary. 2016 Aug;19(4):415-21. doi: 10.1007/s11102-016-0721-6.

21.

Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.

Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE.

J Neurosurg. 2017 Jan;126(1):319-329. doi: 10.3171/2015.12.JNS152443. Epub 2016 Apr 1.

22.

Key considerations in the treatment of von Hippel-Lindau disease.

Pilié PG, Jonasch E, McCutcheon IE.

Future Oncol. 2016 Aug;12(15):1755-8. doi: 10.2217/fon-2016-0028. Epub 2016 Mar 29. No abstract available.

PMID:
27020706
23.

Neurofibromas of the Phrenic Nerve: A Case Report and Review of the Literature.

Ghali MG, Srinivasan VM, Jea A, Slopis JM, McCutcheon IE.

World Neurosurg. 2016 Apr;88:237-42. doi: 10.1016/j.wneu.2015.12.076. Epub 2015 Dec 31. Review.

PMID:
26746336
24.

Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor.

Kivlin CM, Watson KL, Al Sannaa GA, Belousov R, Ingram DR, Huang KL, May CD, Bolshakov S, Landers SM, Kalam AA, Slopis JM, McCutcheon IE, Pollock RE, Lev D, Lazar AJ, Torres KE.

Cancer Biol Ther. 2016;17(2):129-38. doi: 10.1080/15384047.2015.1108486. Epub 2015 Dec 9.

25.

Factors affecting survival in 43 consecutive patients after surgery for spinal metastases from thyroid carcinoma.

Sellin JN, Suki D, Harsh V, Elder BD, Fahim DK, McCutcheon IE, Rao G, Rhines LD, Tatsui CE.

J Neurosurg Spine. 2015 Oct;23(4):419-28. doi: 10.3171/2015.1.SPINE14431. Epub 2015 Jul 3.

PMID:
26140400
26.

Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations.

Juratli TA, Cahill DP, McCutcheon IE.

Expert Rev Anticancer Ther. 2015 Jun;15(6):603-6. doi: 10.1586/14737140.2015.1047351. Epub 2015 May 17.

27.

Prognostic Factors Influencing the Outcome of 64 Consecutive Patients Undergoing Surgery for Metastatic Melanoma of the Spine.

Sellin JN, Gressot LV, Suki D, St Clair EG, Chern J, Rhines LD, McCutcheon IE, Rao G, Tatsui CE.

Neurosurgery. 2015 Sep;77(3):386-93; discussion 393. doi: 10.1227/NEU.0000000000000790.

PMID:
25933368
28.

Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review.

Ferguson SD, Waguespack SG, Langford LA, Ater JL, McCutcheon IE.

Childs Nerv Syst. 2015 May;31(5):777-84. doi: 10.1007/s00381-014-2604-3. Epub 2014 Dec 12. Review.

PMID:
25503249
29.

C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.

Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD.

Brain Tumor Pathol. 2015 Apr;32(2):105-11. doi: 10.1007/s10014-014-0205-1. Epub 2014 Nov 12.

30.

Impact of preoperative functional magnetic resonance imaging during awake craniotomy procedures for intraoperative guidance and complication avoidance.

Trinh VT, Fahim DK, Maldaun MV, Shah K, McCutcheon IE, Rao G, Lang F, Weinberg J, Sawaya R, Suki D, Prabhu SS.

Stereotact Funct Neurosurg. 2014;92(5):315-22. doi: 10.1159/000365224. Epub 2014 Sep 18.

PMID:
25247627
31.

Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD Anderson Cancer Center experience.

Tsai CJ, Wang Y, Allen PK, Mahajan A, McCutcheon IE, Rao G, Rhines LD, Tatsui CE, Armstrong TS, Maor MH, Chang EL, Brown PD, Li J.

Neurosurgery. 2014 Sep;75(3):205-14; discussion 213-4. doi: 10.1227/NEU.0000000000000408.

PMID:
24818785
32.

Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Kim BYS, Jiang W, Beiko J, Prabhu SS, DeMonte F, Gilbert MR, Sawaya R, Aldape KD, Cahill DP, McCutcheon IE.

J Neurooncol. 2014 Jun;118(2):405-412. doi: 10.1007/s11060-014-1451-0. Epub 2014 Apr 29.

33.

The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors.

Khiewvan B, Macapinlac HA, Lev D, McCutcheon IE, Slopis JM, Al Sannaa G, Wei W, Chuang HH.

Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1756-66. doi: 10.1007/s00259-014-2756-0. Epub 2014 Apr 4.

PMID:
24699907
34.

Multidetector CT with 3-dimensional volume rendering in the evaluation of the spine in patients with Neurofibromatosis type 1: a retrospective review in 73 patients.

Debnam JM, Mahfouz YM, Ketonen L, Slopis JM, McCutcheon IE, Guha-Thakurta N.

Scoliosis. 2014 Sep 23;9:15. doi: 10.1186/1748-7161-9-15. eCollection 2014.

35.

Transsphenoidal removal of intrasellar pilocytic astrocytoma.

Prashant Prasad G, Lang FF, Bruner JM, Ater JL, McCutcheon IE.

J Clin Neurosci. 2014 Jun;21(6):1047-8. doi: 10.1016/j.jocn.2013.10.004. Epub 2013 Oct 23.

PMID:
24308951
36.

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, Shonka N, Gilbert MR, Sawaya R, Prabhu SS, Weinberg J, Lang FF, Aldape KD, Sulman EP, Rao G, McCutcheon IE, Cahill DP.

Neuro Oncol. 2014 Jan;16(1):81-91. doi: 10.1093/neuonc/not159. Epub 2013 Dec 4.

37.

Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.

Verma J, McCutcheon IE, Waguespack SG, Mahajan A.

Pituitary. 2014 Dec;17(6):539-45. doi: 10.1007/s11102-013-0541-x.

PMID:
24272035
38.

Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma.

Tatsui CE, Suki D, Rao G, Kim SS, Salaskar A, Hatiboglu MA, Gokaslan ZL, McCutcheon IE, Rhines LD.

J Neurosurg Spine. 2014 Jan;20(1):108-16. doi: 10.3171/2013.9.SPINE13158. Epub 2013 Nov 8.

PMID:
24206037
39.

Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy.

Ghia AJ, Chang EL, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD.

Neurosurgery. 2013 Oct;73(4):624-30; discussion 630-1. doi: 10.1227/NEU.0000000000000064.

PMID:
23839520
40.

Stereotactic radiosurgery for malignant extracerebral intracranial tumors: patient selection, efficacy, and technical nuances.

McCutcheon IE.

Acta Neurochir Suppl. 2013;116:71-83. doi: 10.1007/978-3-7091-1376-9_12. Review.

PMID:
23417462
41.

A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors.

Wu AS, Trinh VT, Suki D, Graham S, Forman A, Weinberg JS, McCutcheon IE, Prabhu SS, Heimberger AB, Sawaya R, Wang X, Qiao W, Hess K, Lang FF.

J Neurosurg. 2013 Apr;118(4):873-883. doi: 10.3171/2012.12.JNS111970. Epub 2013 Feb 8.

42.

Pituitary adenomas: Surgery and radiotherapy in the age of molecular diagnostics and pathology.

McCutcheon IE.

Curr Probl Cancer. 2013 Jan-Feb;37(1):6-37. doi: 10.1016/j.currproblcancer.2012.10.001. Review. No abstract available.

PMID:
23391140
43.

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.

Fakhreddine MH, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon IE, Puduvalli V, Brown PD.

Neuro Oncol. 2013 Apr;15(4):406-12. doi: 10.1093/neuonc/nos309. Epub 2013 Jan 14.

44.

Binding partners for curcumin in human schwannoma cells: biologic implications.

Angelo LS, Maxwell DS, Wu JY, Sun D, Hawke DH, McCutcheon IE, Slopis JM, Peng Z, Bornmann WG, Kurzrock R.

Bioorg Med Chem. 2013 Feb 15;21(4):932-9. doi: 10.1016/j.bmc.2012.12.008. Epub 2012 Dec 13.

PMID:
23294827
45.

Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis.

Ghia AJ, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD.

Neurosurgery. 2013 Feb;72(2):203-9. doi: 10.1227/NEU.0b013e31827b9e68.

PMID:
23149953
46.

Subcortical injury is an independent predictor of worsening neurological deficits following awake craniotomy procedures.

Trinh VT, Fahim DK, Shah K, Tummala S, McCutcheon IE, Sawaya R, Suki D, Prabhu SS.

Neurosurgery. 2013 Feb;72(2):160-9. doi: 10.1227/NEU.0b013e31827b9a11.

PMID:
23147778
47.

Glioblastoma resection.

Lang FF, Sawaya R, Suki D, McCutcheon IE, Hess KR.

J Neurosurg. 2012 May;116(5):1166-7; author reply 1167-8. doi: 10.3171/2011.8.JNS11637c. Epub 2012 Mar 2. No abstract available.

PMID:
22385007
48.

Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.

Kim BY, Jonasch E, McCutcheon IE.

Target Oncol. 2012 Jun;7(2):145-9. doi: 10.1007/s11523-012-0214-0. Epub 2012 Feb 29.

49.

Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside.

Subbiah V, Slopis J, Hong DS, Ketonen LM, Hamilton J, McCutcheon IE, Kurzrock R.

J Clin Oncol. 2012 Feb 10;30(5):e64-8. doi: 10.1200/JCO.2011.38.2614. Epub 2011 Dec 27. No abstract available.

50.

Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.

Hightower E, Cabanillas ME, Fuller GN, McCutcheon IE, Hess KR, Shah K, Waguespack SG, Corley LJ, Devin JK.

Pituitary. 2012 Dec;15(4):556-61. doi: 10.1007/s11102-011-0367-3.

Supplemental Content

Loading ...
Support Center